• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性血栓闭塞性脉管炎(伯格氏病)(重新评估)

Thromboangiitis obliterans (Buerger's disease) in women (a reevaluation).

作者信息

Yörükoğlu Y, Ilgit E, Zengin M, Nazliel K, Salman E, Yucel E

机构信息

Department of Cardiovascular Surgery, Gazi University, Medical School, Ankara, Turkey.

出版信息

Angiology. 1993 Jul;44(7):527-32. doi: 10.1177/000331979304400704.

DOI:10.1177/000331979304400704
PMID:8328680
Abstract

Thromboangiitis obliterans (TAO) is an occlusive vascular disease traditionally known to be almost exclusive to young male smokers. The disease was considered to be extremely rare in women, seen only as isolated, novel case reports in the literature. In the past decade, however, a dramatic increase in the incidence of female TAO has been observed. In this paper the authors report 7 cases of clinically and angiographically verified female TAO. The world literature in regard to the diagnostic criteria, changing incidence, and etiology is reviewed. They conclude that the increased use of tobacco among young women in the past two to three decades is responsible for this dramatic change.

摘要

血栓闭塞性脉管炎(TAO)是一种闭塞性血管疾病,传统上认为几乎仅见于年轻男性吸烟者。该疾病在女性中被认为极为罕见,在文献中仅作为孤立的新病例报告出现。然而,在过去十年中,女性TAO的发病率显著增加。在本文中,作者报告了7例经临床和血管造影证实的女性TAO病例。并对世界文献中关于诊断标准、发病率变化和病因进行了综述。他们得出结论,过去二三十年年轻女性烟草使用的增加是造成这一显著变化的原因。

相似文献

1
Thromboangiitis obliterans (Buerger's disease) in women (a reevaluation).女性血栓闭塞性脉管炎(伯格氏病)(重新评估)
Angiology. 1993 Jul;44(7):527-32. doi: 10.1177/000331979304400704.
2
Thromboangiitis obliterans. An update on Buerger's disease.血栓闭塞性脉管炎。关于伯格氏病的最新进展。
West J Med. 1998 Apr;168(4):255-60.
3
Thromboangiitis obliterans (Buerger's disease) in an elderly man after cessation of cigarette smoking--a case report.一名老年男性戒烟后发生血栓闭塞性脉管炎(伯格氏病)——病例报告
Angiology. 1987 Nov;38(11):864-7. doi: 10.1177/000331978703801110.
4
Politics, culture, and the legitimacy of disease: the case of Buerger's disease.政治、文化与疾病的正当性:以血栓闭塞性脉管炎为例
Clin Rheumatol. 2016 Sep;35(9):2145-9. doi: 10.1007/s10067-016-3310-1. Epub 2016 May 18.
5
Buerger's disease in two brothers: iliac artery occlusion by thromboangiitis obliterans--case reports.两兄弟患血栓闭塞性脉管炎致髂动脉闭塞——病例报告
Angiology. 1998 May;49(5):409-14. doi: 10.1177/000331979804900511.
6
[Thromboangiitis obliterans (Buerger's disease) in 2 women].两名女性患血栓闭塞性脉管炎(伯格氏病)
Ned Tijdschr Geneeskd. 1996 Aug 31;140(35):1770-2.
7
Thromboangiitis obliterans (Buerger's disease) in women.女性血栓闭塞性脉管炎(伯格氏病)
Medicine (Baltimore). 1987 Jan;66(1):65-72. doi: 10.1097/00005792-198701000-00002.
8
The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease).血栓闭塞性脉管炎(伯格氏病)的兴衰与复苏
Acta Pathol Jpn. 1989 Mar;39(3):153-8. doi: 10.1111/j.1440-1827.1989.tb01494.x.
9
[Buerger's disease or thromboangiitis obliterans revealed by an enteric ischemia. Case report and literature review].[以肠道缺血为表现的血栓闭塞性脉管炎(伯格氏病)。病例报告及文献综述]
Gastroenterol Clin Biol. 2002 Apr;26(4):409-11.
10
Thromboangiitis obliterans (Buerger's disease) in a saphenous vein arterial graft.大隐静脉动脉移植物中的血栓闭塞性脉管炎(伯格氏病)
Hum Pathol. 1987 Apr;18(4):402-4. doi: 10.1016/s0046-8177(87)80174-0.

引用本文的文献

1
Thoracoscopic dorsal sympathectomy for upper limb Buerger's disease.胸腔镜下胸交感神经切除术治疗上肢血栓闭塞性脉管炎
JSLS. 2014 Apr-Jun;18(2):273-6. doi: 10.4293/108680813X13753907292755.
2
Thromoboagiitis Obliterans (TAO).血栓闭塞性脉管炎(TAO)。
Int J Stem Cells. 2010 May;3(1):1-7. doi: 10.15283/ijsc.2010.3.1.1.
3
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan.波生坦治疗血栓闭塞性脉管炎(伯格氏病)。
BMC Cardiovasc Disord. 2012 Feb 14;12:5. doi: 10.1186/1471-2261-12-5.
4
Thromboangiitis obliterans. An update on Buerger's disease.血栓闭塞性脉管炎。关于伯格氏病的最新进展。
West J Med. 1998 Apr;168(4):255-60.